Oxidative stress mediates tau-induced neurodegeneration in Drosophila

被引:250
作者
Dias-Santagata, Dora
Fulga, Tudor A.
Duttaroy, Atanu
Feany, Mel B.
机构
[1] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Howard Univ, Dept Biol, Washington, DC 20059 USA
关键词
D O I
10.1172/JCI28769
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Markers of oxidative damage have been detected in brain tissue from patients with Alzheimer disease (AD) and other neurodegenerative disorders. These findings implicate oxidative injury in the neurodegenerative process, but whether oxidative stress is a cause or a consequence of neurotoxicity remains unclear. We used a Drosophila model of human tauopathies to investigate the role of oxidative stress in neurodegeneration. Genetic and pharmacological manipulation of antioxidant defense mechanisms significantly modified neurodegeneration in our model, suggesting that oxidative stress plays a causal role in neurotoxicity. We demonstrate that the JNK signaling pathway is activated in our model, which is in agreement with previous findings in AD tissue. Furthermore, we show that the extent of JNK activation correlates with the degree of tau-induced neurodegeneration. Finally, our findings suggest that oxidative stress acts not to promote tau phosphorylation, but to enhance tau-induced cell cycle activation. In summary, our study identifies oxidative stress as a causal factor in tau-induced neurodegeneration in Drosophila.
引用
收藏
页码:236 / 245
页数:10
相关论文
共 61 条
[1]   Oxidative stress in neurodegeneration: cause or consequence? [J].
Andersen, JK .
NATURE MEDICINE, 2004, 10 (07) :S18-S25
[2]   Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms [J].
Andorfer, C ;
Acker, CM ;
Kress, Y ;
Hof, PR ;
Duff, K ;
Davies, P .
JOURNAL OF NEUROSCIENCE, 2005, 25 (22) :5446-5454
[3]   ELEVATED PARAQUAT RESISTANCE CAN BE USED AS A BIOASSAY FOR LONGEVITY IN A GENETICALLY BASED LONG-LIVED STRAIN OF DROSOPHILA [J].
ARKING, R ;
BUCK, S ;
BERRIOS, A ;
DWYER, S ;
BAKER, GT .
DEVELOPMENTAL GENETICS, 1991, 12 (05) :362-370
[4]   Vitamin C and vitamin E for Alzheimer's disease [J].
Boothby, LA ;
Doering, PL .
ANNALS OF PHARMACOTHERAPY, 2005, 39 (12) :2073-2080
[5]  
Busser J, 1998, J NEUROSCI, V18, P2801
[6]   NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease [J].
Colton, C. A. ;
Vitek, M. P. ;
Wink, D. A. ;
Xu, Q. ;
Cantillana, V. ;
Previti, M. L. ;
Van Nostrand, W. E. ;
Weinberg, B. ;
Dawson, H. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (34) :12867-12872
[7]   Vitamin E reduces amyloidosis and improves cognitive function in Tg2576 mice following repetitive concussive brain injury [J].
Conte, V ;
Uryu, K ;
Fujimoto, S ;
Yao, Y ;
Rokach, J ;
Longhi, L ;
Trojanowski, JQ ;
Lee, VMY ;
McIntosh, TK ;
Praticò, D .
JOURNAL OF NEUROCHEMISTRY, 2004, 90 (03) :758-764
[8]   Drug therapy - Alzheimer's disease [J].
Cummings, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (01) :56-67
[9]  
Duttaroy A, 2003, GENETICS, V165, P2295
[10]   Pro-apoptotic effects of tau mutations in chromosome 17 frontotemporal dementia and parkinsonism [J].
Furukawa, K ;
D'Souza, I ;
Crudder, CH ;
Onodera, H ;
Itoyama, Y ;
Poorkaj, P ;
Bird, TD ;
Schellenberg, GD .
NEUROREPORT, 2000, 11 (01) :57-60